Large bone defects secondary to tumor or trauma and fracture-delayed unions often require bone regeneration enhancements, but the precise mechanisms involved in bone healing have remained clear. In September 15
Hairong Peng et al. used muscle-derived stem cells genetically engineered to express human BMP-4, VEGF or VEGF-specific antagonist. They observed that although VEGF alone did not improve bone regeneration, it acted synergistically with BMP-4 to increase recruitment of mesenchymal stem cells, enhance cell survival and to augment cartilage formation in the early stages of endochondral bone formation.
In addition, they showed that the beneficial effect of VEGF on bone healing elicited by BMP4 depends critically ...